Intangible assets excluding goodwill

The changes during 2008 were as follows:

Other intangible assets in 2008 consist of:

The estimated amortization expense for these other intangible assets for each of the five succeeding years is:

The expected weighted average remaining life of other intangibles is 11.5 years as of December 31, 2008.

The additions acquired through business combinations in 2008 consist of the acquired intangible assets of Respironics of EUR 1,186 million, Genlyte of EUR 860 million, and VISICU of EUR 33 million.

The acquired intangible assets mainly consist of customer relationships and patents for Respironics of EUR 732 million and Genlyte of EUR 614 million, and core and existing technology for Respironics of EUR 355 million and VISICU of EUR 20 million.

The unamortized costs of computer software to be sold, leased or otherwise marketed amounted to EUR 102 million (2007: EUR 63 million). The amounts charged to the income statement for amortization or impairment of these capitalized computer software costs amounted to EUR 26 million (2007: EUR 20 million).